The renewal price, printed
Almost every seller in this comparison publishes a price to sign up at. HealthRX publishes that and what happens at the end of the term, in a column headed with the word renews. It also explains why the two differ: a standing credit applied to every renewal. Layla and AM Rx both publish the rate that follows their first-month offer, which is the same idea attached to one tier; HealthRX attaches it to all four.
There is a second pair of figures alongside — a subscribe-and-save route with a lower first month and a higher ongoing rate, stated in the same paragraph. Between the plan table and that paragraph, four distinct prices exist for each drug and all four are printed.
The headline is a year
As with much of this market, the figures the page leads with are the twelve-month tiers, and the one-month rate for both drugs is roughly double. The difference here is that the page does not require you to hunt: the whole ladder, with totals, is in one table.
It states plainly that there are no separate visit fees and no membership fees, which settles a question most sellers here leave open.
Nobody signs the page
We read four pages on this host and ran a widened corporate-suffix pattern across all of them. The only corporate name anywhere is the arbitration administrator named inside its own arbitration clause — a well-known false positive that has now turned up on a great many sites in this market.
The compounding pharmacy is described by licensing class rather than named. No individual clinician is named. No service area is published. And the page compares its own figure to a brand-name cash price it states itself, which is a comparison it constructs rather than measures.
HealthRX's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $190/mothe one-month plan, billed monthly, published beside a "Renews at" column of $165; the Subscribe & Save route is $149 for the first month and $165 after it | September 2026source |
| Semaglutide (compounded) | $99the twelve-month plan, published as $1,188 billed once and renewing at $1,163; $99 is that total divided by twelve and is not a monthly payment | September 2026source |
| Tirzepatide (compounded) | $239/mothe one-month plan, billed monthly, published beside a "Renews at" column of $214; the Subscribe & Save route is $193 for the first month and $214 after it | September 2026source |
| Tirzepatide (compounded) | $179the twelve-month plan, published as $2,148 billed once and renewing at $2,123; $179 is that total divided by twelve and is not a monthly payment | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 198 providers reviewed here are paid partners today; the other 194 are not. See how this works.
See HealthRX's current price →Good fit if
- Readers who want to know the renewal price before signing up rather than after.
- Buyers comparing a subscribe-and-save route against a prepaid plan from the same seller.
- People who want a plan total printed beside every per-month figure.
- Anyone who wants the membership question answered plainly.
Look elsewhere if
- Readers who need to know which company they are contracting with.
- Buyers who want a named compounding pharmacy or a named prescribing clinician.
- Anyone who needs a service-area list.
- Readers who would mistake the headline for a month-to-month rate.
How this review was verified
- Re-read the pricing page, the homepage, the about page and the editorial policy on 7 September 2026, comparing requested to effective URLs and running a nonsense path against the host in the same run, which returned a 404.
- Recorded every tier of both ladders, including the renewal column and the subscribe-and-save first-month rates, and stored the twelve-month tiers as non-monthly with the prepaid total in the qualifier.
- Ran a widened corporate-suffix pattern — including Co., Company, Ltd, LLP, PLLC, PC, PA and Corp — across every cached body, proved first against a page known to name a company. The single match was the arbitration administrator inside the arbitration clause, read in context and rejected.
- Excluded the brand-name cash price the seller quotes from every stored figure, because it is the seller's own comparison and not a measurement.
- Screened two spellings of the brand against FDA's live warning-letter datatable with a positive control and a nonsense negative control in the same invocation; both returned zero matches, so the absence is measured rather than assumed.